BYNFEZIA Pen
NDC 62756-452, octreotide acetate, injection, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 62756-452
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213224
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62756-452 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTREOTIDE ACETATE2.5 mg/mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62756-452-36 | 62756045236 | 1 CARTRIDGE in 1 CARTON (62756-452-36) / 2.8 mL in 1 CARTRIDGE |
| 62756-452-37 | 62756045237 | 2 CARTRIDGE in 1 CARTON (62756-452-37) / 2.8 mL in 1 CARTRIDGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/20ed4e79-ad4c-426f-859d-83790c00439b
Use it
Look up 62756-452 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62756-452 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62756-452. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.